ArticleNeuropharmacology2019

Positive allosteric modulation of the type 1 cannabinoid receptor reduces the signs and symptoms of Huntington's disease in the R6/2 mouse model.

Robert B Laprairie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.